rxstat › Shortages › Dipyridamole

Dipyridamole shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Dipyridamole has no current shortage reported in Canada. It has been in shortage before; the history is below.
Products affected
0 / 5
Reports on file
21

Reports by product

Resolved
PERSANTINE
5MG · SOLUTION · GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE
DIN 00637734 · ended Apr 28, 2026 · Disruption of the manufacture of the drug.
Resolved
DIPYRIDAMOLE INJECTION, USP
5MG · LIQUID · FRESENIUS KABI CANADA LTD
DIN 02244475 · ended Jun 30, 2024 · Disruption of the manufacture of the drug.
Resolved
PERSANTINE
5MG · SOLUTION · GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE
DIN 00637734 · ended Feb 8, 2024 · Disruption of the manufacture of the drug.
Resolved
DIPYRIDAMOLE INJECTION, USP
5MG · LIQUID · FRESENIUS KABI CANADA LTD
DIN 02244475 · ended Feb 28, 2023 · Other (Please describe in comments)
Resolved
DIPYRIDAMOLE INJECTION, USP
5MG · LIQUID · FRESENIUS KABI CANADA LTD
DIN 02244475 · ended Oct 1, 2021 · Disruption of the manufacture of the drug.
Discontinued
APO-DIPYRIDAMOLE-FC TAB 25MG
25MG · TABLET · APOTEX INC
DIN 00895644
Discontinued
APO-DIPYRIDAMOLE-FC TAB 50MG
50MG · TABLET · APOTEX INC
DIN 00895652
Resolved
DIPYRIDAMOLE INJECTION, USP
5MG · LIQUID · FRESENIUS KABI CANADA LTD
DIN 02244475 · ended Apr 24, 2020 · Disruption of the manufacture of the drug.
Resolved
DIPYRIDAMOLE INJECTION, USP
5MG · LIQUID · FRESENIUS KABI CANADA LTD
DIN 02244475 · ended Feb 12, 2020 · Disruption of the manufacture of the drug.
Discontinued
APO-DIPYRIDAMOLE-FC TAB 75MG
75MG · TABLET · APOTEX INC
DIN 00895660
Resolved
DIPYRIDAMOLE INJECTION, USP
5MG · LIQUID · FRESENIUS KABI CANADA LTD
DIN 02244475 · ended Oct 1, 2019 · Disruption of the manufacture of the drug.
Resolved
DIPYRIDAMOLE INJECTION, USP
5MG · LIQUID · FRESENIUS KABI CANADA LTD
DIN 02244475 · ended Mar 18, 2019 · Disruption of the manufacture of the drug.

Showing 12 of 21 reports. All reports are on file with Health Canada.

What's happening

There are no active shortage reports for Dipyridamole. Health Canada has 21 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Dipyridamole is classified under “ANTITHROMBOTIC AGENTS” (ATC B01AC).

Recent changes

Common questions

When will Dipyridamole be back in stock in Canada?

Dipyridamole has no active shortage; supply is normal per Health Canada reports.

Why is Dipyridamole in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antithrombotic agents)

Widespread shortageNadroparin7 of 8 reported products affectedWidespread shortageTicagrelor2 of 4 reported products affected · est. return Jul 31, 2026Partial shortageBivalirudin1 of 3 reported products affected · est. return Jun 30, 2026Partial shortageClopidogrel4 of 18 reported products affected · est. return Nov 10, 2026Partial shortageDabigatran Etexilate2 of 6 reported products affected · est. return Jun 12, 2026Partial shortageEdoxaban1 of 6 reported products affected · est. return Jul 10, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.